Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
KABRA DRUGS LTD.
Kabra Drugs Ltd.
BSE: 524322
Download real time
19.75
-1.03
(
-4.96
%)
New 52W High in past week
41,225
BSE Volume
High vol. this week
BSE
11 Jul, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Kabra Drugs Ltd. - KABRADG, 524322 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Kabra Drugs Ltd.
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Kabra Drugs Ltd. Bonus history
Kabra Drugs Ltd. has not announced any bonus since Jan 1, 2000.
See all forthcoming Bonus and Splits
Kabra Drugs Ltd. Split history
Kabra Drugs Ltd. has not split the face value of the share since Jan 1, 2000.
See all forthcoming Bonus and Splits
Kabra Drugs Ltd. Dividend history
Kabra Drugs Ltd. has not given any dividends since Jan 1, 2000.
See all forthcoming dividends
Board Meetings - Kabra Drugs Ltd.
The latest board meeting for Kabra Drugs Ltd. took place on 18 Jun 2025, for the purpose of Others
Ex-Date
Purpose
Notes
18 Jun 2025
Others
Inter-alia, to consider 1. New acquisition. 2. New drug license for a Chennai office. 3. Diversification by creating new subsidiary. 4. Other business matters.
30 May 2025
Audited Results
-
14 Feb 2025
Quarterly Results
-
14 Nov 2024
Quarterly Results
-
04 Nov 2024
Others
-
14 Aug 2024
Quarterly Results
-
12 Jul 2024
Others
Inter alia, 1. To consider and change the registered office of the Company within the local limits of city where the registered office of the company is presently situated;
30 May 2024
Audited Results
-
14 Feb 2024
Quarterly Results
-
23 Jan 2024
Preferential issue of shares
-
See all Board Meetings for Kabra Drugs Ltd.
Kabra Drugs Ltd. Rights history
Kabra Drugs Ltd. has not issued
any
rights since Jan 1, 2000.
See all Rights History for Kabra Drugs Ltd.